BCL2 and neoplasm: Consistent with this hypothesis, we found that multiple BCL2 proteins are transcribed in the primary tumor and early, midpoint, and late metastases, with MCL1 being significantly more abundant compared to other anti-apoptotic factors regardless of the time point (Fig. 5B).